Rates of remission/euthymia with quetiapine monotherapy compared with placebo in patients with acute mania

Journal of Affective Disorders

Volumn 100, Issue SUPPL. 1, 2007, Pages

  Ketter, Terence A ^a   Jones, Martin ^b   Paulsson, Björn ^c  

^a STANFORD UNIVERSITY   (United States)

^b ASTRAZENECA   (United Kingdom)

^c ASTRAZENECA R AND D   (Sweden)

Author keywords

Bipolar disorder; Euthymia; Mania; Quetiapine; Remission

Indexed keywords

PLACEBO; QUETIAPINE;

ARTICLE; BIPOLAR I DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG DOSE ESCALATION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; HEADACHE; HUMAN; INSOMNIA; MANIA; META ANALYSIS; MONOTHERAPY; MONTGOMERY ASBERG DEPRESSION RATING SCALE; PRIORITY JOURNAL; RATING SCALE; REMISSION; SIDE EFFECT; SLEEP DISORDER; SOMNOLENCE; SYSTEMATIC REVIEW; WEIGHT GAIN; XEROSTOMIA; YOUNG MANIA RATING SCALE;

ACUTE DISEASE; ADOLESCENT; ADULT; AFFECT; AGED; ANTIMANIC AGENTS; BIPOLAR DISORDER; DIBENZOTHIAZEPINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTICENTER STUDIES; PSYCHIATRIC STATUS RATING SCALES; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 34249285468     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2007.02.006     Document Type: Article

References (29)

1. Adler C.M., Fleck D.E., Brecher M., and Strakowski S.M. Safety and tolerability of quetiapine in the treatment of acute mania in bipolar disorder. J. Affect. Disord. 100 (2007) S15-S22 10.1016/j.jad.2007.02.004 (this issue)
2. American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder (revision). Am. J. Psychiatry 159 (2002) 1-50
3. Bowden C.L., Brugger A.M., Swann A.C., Calabrese J.R., Janicak P.G., Petty F., Dilsaver S.C., Davis J.M., Rush A.J., Small J.G., et al. Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group. JAMA 271 (1994) 918-924
4. Bowden C., Grunze H., Mullen J., Brecher M., Paulsson B., Jones M., Vågerö M., and Svensson K. A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder. J. Clin. Psychiatry 66 (2005) 111-121
5. Calabrese J.R., Bowden C.L., Sachs G.S., Ascher J.A., Monaghan E., and Rudd G.D. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. J. Clin. Psychiatry 60 (1999) 79-88
6. Calabrese J.R., Keck Jr. P.E., Macfadden W., Minkwitz M., Ketter T.A., Weisler R.H., Cutler A.J., McCoy R., Wilson E., and Mullen J. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am. J. Psychiatry 162 (2005) 1351-1360
7. Canuso C., Zhu Y., Bossie C., and Grossman F. Remission with risperidone in combination with mood stabilizers in acute bipolar mania (abstract P35). Bipolar Disord. 5 (2003) 38
8. Chengappa K.N., Baker R.W., Shao L., Yatham L.N., Tohen M., Gershon S., and Kupfer D.J. Rates of response, euthymia and remission in two placebo-controlled olanzapine trials for bipolar mania. Bipolar Disord. 5 (2003) 1-5
9. Chengappa K.N.R., Hennen J., Baldessarini R.J., Kupfer D.J., Yatham L.N., Gershon S., Baker R.W., and Tohen M. Recovery and functional outcomes following olanzapine treatment for bipolar I mania. Bipolar Disord. 7 (2005) 68-76
10. Endicott J., Nee J., Harrison W., and Blumenthal R. Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacol. Bull. 29 (1993) 321-326
11. Gopal S., Steffenns D.C., Kramer M.L., and Olsen M.K. Symptomatic remission in patients with bipolar mania: results from a double-blind, placebo-controlled trial of risperidone monotherapy. J. Clin. Psychiatry 66 (2005) 1016-1020
12. Hirschfeld R.M., Keck Jr. P.E., Kramer M., Karcher K., Canuso C., Eerdekens M., and Grossman F. Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial. Am. J. Psychiatry 161 (2004) 1057-1065
13. Keck Jr. P.E., Marcus R., Tourkodimitris S., Ali M., Liebeskind A., Saha A., and Ingenito G. A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania. Am. J. Psychiatry 160 (2003) 1651-1658
14. Keck Jr. P.E., Versiani M., Potkin S., West S.A., Giller E., and Ice K. Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial. Am. J. Psychiatry 160 (2003) 741-748
15. Maj M., Pirozzi R., Magliano L., and Bartoli L. The prognostic significance of "switching" in patients with bipolar disorder: a 10-year prospective follow-up study. Am. J. Psychiatry 159 (2002) 1711-1717
16. McIntyre R.S., Brecher M., Paulsson B., Huizar K., and Mullen J. Quetiapine or haloperidol as monotherapy for bipolar mania-a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial. Eur. Neuropsychopharmacol. 15 (2005) 573-585
17. Montgomery S.A., and Asberg M. A new depression scale designed to be sensitive to change. Br. J. Psychiatry 134 (1979) 382-389
18. Smulevich A.B., Khanna S., Eerdekens M., Karcher K., Kramer M., and Grossman F. Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol. Eur. Neuropsychopharmacol. 15 (2005) 75-84
19. Strakowski S.M., Williams J.R., Fleck D.E., and Delbello M.P. Eight-month functional outcome from mania following a first psychiatric hospitalization. J. Psychiatr. Res. 34 (2000) 193-200
20. Tohen M., Sanger T.M., McElroy S.L., Tollefson G.D., Chengappa K.N., Daniel D.G., Petty F., Centorrino F., Wang R., Grundy S.L., Greaney M.G., Jacobs T.G., David S.R., and Toma V. Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group. Am. J. Psychiatry 156 (1999) 702-709
21. Tohen M., Jacobs T.G., Grundy S.L., McElroy S.L., Banov M.C., Janicak P.G., Sanger T., Risser R., Zhang F., Toma V., Francis J., Tollefson G.D., and Breier A. Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzapine HGGW Study Group. Arch. Gen. Psychiatry 57 (2000) 841-849
22. Tohen M., Baker R.W., Altshuler L.L., Zarate C.A., Suppes T., Ketter T.A., Milton D.R., Risser R., Gilmore J.A., Breier A., and Tollefson G.A. Olanzapine versus divalproex in the treatment of acute mania. Am. J. Psychiatry 159 (2002) 1011-1017
23. Tohen M., Goldberg J.F., Gonzalez-Pinto Arrillaga A.M., Azorin J.M., Vieta E., Hardy-Bayle M.C., Lawson W.B., Emsley R.A., Zhang F., Baker R.W., Risser R.C., Namjoshi M.A., Evans A.R., and Breier A. A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania. Arch. Gen. Psychiatry 60 (2003) 1218-1226
24. Tohen M., Vieta E., Calabrese J., Ketter T.A., Sachs G., Bowden C., Mitchell P.B., Centorrino F., Risser R., Baker R.W., Evans A.R., Beymer K., Dube S., Tollefson G.D., and Breier A. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch. Gen. Psychiatry 60 (2003) 1079-1088
25. Vieta E., Calabrese J.R., Hennen J., Colom F., Martinez-Aran A., Sanchez-Moreno J., Yatham L.N., Tohen M., and Baldessarini R.J. Comparison of rapid-cycling and non-rapid-cycling bipolar I manic patients during treatment with olanzapine: analysis of pooled data. J. Clin. Psychiatry 65 (2004) 1420-1428
26. Vieta E., Bourin M., Sanchez R., Marcus R., Stock E., McQuade R., Carson W., Abou-Gharbia N., Swanink R., and Iwamoto T. Effectiveness of aripiprazole v. haloperidol in acute bipolar mania: double-blind, randomised, comparative 12-week trial. Br. J. Psychiatry 187 (2005) 235-242
27. Vieta E., Goldberg J.F., Mullen J., Vagero M., and Paulsson B. Quetiapine in the treatment of acute mania: Target dose for efficacious treatment. J. Affect. Disord. 100 (2007) S23-S31 10.1016/j.jad.2007.02.009 (this issue)
28. Weisler R.H., Kalali A.H., and Ketter T.A. A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes. J. Clin. Psychiatry 65 (2004) 478-484
29. Young R.C., Biggs J.T., Ziegler V.E., and Meyer D.A. A rating scale for mania: reliability, validity and sensitivity. Br. J. Psychiatry 133 (1978) 429-435